19 August 2022

Dear Prescriber / Hospital Pharmacist

RE: THERAKOS® CELLEX™ Photopheresis System

Ikaria Australia Pty Ltd, a Mallinckrodt Pharmaceuticals company, is pleased to provide the THERAKOS™ CELLEX™ Photopheresis System to the Australian market from today, Friday 19th August 2022.

We are pleased to launch to provide additional information about the clinical use of THERAKOS ™ CELLEX ™ Photopheresis System in Australia.

You will automatically be redirected to the THERAKOS® website in 5 seconds.

Mallinckrodt will also be present at Blood 2022, in Sydney from 11th – 14th September. If you are planning to attend, we look forward to seeing your there and sharing information with you.

In the meantime, if you have any questions about the THERAKOS ™ CELLEX ™ Photopheresis System, please contact our office on 03 9851 9100.

Yours faithfully
Steven Skorobogaty
General Manager – Australia
Mallinckrodt Pharmaceuticals
Ground Floor, 17 Cotham Road Kew VIC 3101 Australia